Mo-tech
Loading...Mo-tech Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
For external use only. When using this product: Avoid application to wounded or infected area. DO NOT use if irritation develops. If so, consult a physician. Wash off immediately with cold water if product comes in contact with eyes. To avoide misuse, do NOT pour out the contents onto different container as doing so will affect product quality. Keep out of open flames. Store at a cool, dry place, away from direct sunlight.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Specialized functioning shampoo for people experiencing hair loss, it supplies nutrition to help prevent loss of hair and catalyzes chemical reactions that help hair and scalp in strengthening, fortifying and nurturing. At the same time, it also helps to fight and keep dandruff off. For best results, use at least twice a week or as directed by a doctor. No conditioner needed.
History
There is currently no drug history available for this drug.
Other Information
There are no additional details available for this product.
Sources
Mo-tech Manufacturers
-
Dong Sung Pharm Co., Ltd.
![Mo-tech (Pyrithione Zinc) Shampoo [Dong Sung Pharm Co., Ltd.]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Mo-tech | Dong Sung Pharm Co., Ltd.
Saturate scalp and hair with warm water before dispensing about 3-5ml of product for application. Massage thoroughly onto scalp and hair in order to create enough foam. Wait more than 3 minutes to rinse off with tepid water.
-
Dong Sung Pharm Co., Ltd.
Mo-tech | International Medication Systems, Limited
For peripheral vein administration:
Injection of the solution should be made slowly. The maximum rate at which dextrose can be infused without producing glycosuria is 0.5 g/kg of body weight/hour. About 95% of the dextrose is retained when infused at a rate of 0.8 g/kg/hr.
In insulin-induced hypoglycemia, intravenous injection of 10 to 25 grams of dextrose (20 to 50 mL of 50% dextrose) is usually adequate. Repeated doses and supportive treatment may be required in severe cases. A specimen for blood glucose determination should be taken before injecting the dextrose. In such emergencies, dextrose should be administered promptly without awaiting pretreatment test results.
For central vein administration:
For total parenteral nutrition 50% Dextrose Injection, USP is administered by slow intravenous infusion (a) after admixture with amino acid solutions via an indwelling catheter with the tip positioned in a large central vein, preferably the superior vena cava, or (b) after dilution with sterile water for injection. Dosage should be adjusted to meet individual patient requirements.
Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations and acid-base balance during prolonged parenteral therapy or whenever the condition of the patient warrants such evaluation.
The maximum rate of dextrose administration which does not result in glycosuria is the same as cited above.
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. See CONTRAINDICATIONS.
![Mo-tech (Pyrithione Zinc) Shampoo [Dong Sung Pharm Co., Ltd.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=3a9d9c4a-5e4e-4bb6-b2a9-55e1b0b98f02&name=Carton.jpg)
Login To Your Free Account